Department of Psychology, University of Illinois-Urbana-Champaign, Champaign, Illinois.
Alcohol Clin Exp Res. 2019 Oct;43(10):2060-2069. doi: 10.1111/acer.14172. Epub 2019 Aug 30.
The development of a transdermal alcohol biosensor could represent a tremendous advance toward curbing problematic drinking. But several factors limit the usefulness of extant transdermal technology, including relatively lengthy delays between blood alcohol concentration (BAC) and transdermal alcohol concentration (TAC), as well as the large/bulky designs of currently available transdermal sensors (e.g., ankle monitors). The current research examined the lag time between BAC and TAC using a prototype of BACtrack Skyn-a new-generation wrist-worn transdermal sensor featuring a compact design and smartphone integration.
Participants (N = 30) received either a dose of alcohol (target BAC 0.08%) or a nonalcoholic beverage in the laboratory while wearing both the AMS SCRAM ankle monitor and a Skyn prototype. Participants were monitored in the laboratory until breath alcohol concentration (BrAC) dropped below 0.025%.
Device failure rates for Skyn prototypes were relatively high (18 to 38%) compared with nonprototype SCRAM devices (2%). Among participants with usable data, both Skyn- and SCRAM-measured TAC showed strong correlations with BrAC, and both Skyn and SCRAM devices detected alcohol within 30 minutes of first alcohol administration. Skyn-measured TAC peaked over 1 hour earlier than SCRAM-measured TAC (54 versus 120 minutes after peak BrAC, respectively), and time-series models suggested that, on average across all measured portions of the BrAC curve, Skyn TAC lagged behind BrAC by 24 minutes, whereas SCRAM TAC lagged behind BrAC by 69 minutes-all differences statistically significant at p < 0.001.
Results provide preliminary evidence for the validity of a new-generation wrist-worn transdermal sensor under controlled laboratory conditions and further suggest favorable properties of this sensor as they pertain to the latency of transdermal alcohol detection. The prototype version of Skyn employed here displayed a higher failure rate compared with SCRAM, and, in future, more reliable and robust Skyn prototypes will be required suitable to field testing across diverse environmental conditions.
开发一种经皮酒精生物传感器可以极大地促进对饮酒问题的控制。但目前的经皮技术存在一些限制因素,包括血液酒精浓度(BAC)和经皮酒精浓度(TAC)之间存在较长的延迟,以及当前可用的经皮传感器的大/庞大设计(例如,脚踝监视器)。当前的研究使用 BACtrack Skyn 的原型来检查 BAC 和 TAC 之间的滞后时间,这是一种具有紧凑设计和智能手机集成的新一代腕戴式经皮传感器。
参与者(N=30)在实验室中接受酒精剂量(目标 BAC 为 0.08%)或非酒精饮料,同时佩戴 AMS SCRAM 脚踝监视器和 Skyn 原型。参与者在实验室中被监测,直到呼气酒精浓度(BrAC)降至 0.025%以下。
与非原型 SCRAM 设备(2%)相比,Skyn 原型设备的故障率相对较高(18%至 38%)。在有可用数据的参与者中,Skyn 和 SCRAM 测量的 TAC 与 BrAC 均显示出很强的相关性,并且 Skyn 和 SCRAM 设备都在首次饮酒后 30 分钟内检测到酒精。Skyn 测量的 TAC 峰值比 SCRAM 测量的 TAC 早 1 小时以上(分别在达到 BrAC 峰值后 54 分钟和 120 分钟),时间序列模型表明,在 BrAC 曲线的所有测量部分的平均值上,Skyn TAC 滞后于 BrAC 24 分钟,而 SCRAM TAC 滞后于 BrAC 69 分钟-所有差异均具有统计学意义(p<0.001)。
结果为在受控实验室条件下对新一代腕戴式经皮传感器的有效性提供了初步证据,并进一步表明该传感器在经皮酒精检测的潜伏期方面具有有利的特性。此处使用的 Skyn 原型版本与 SCRAM 相比,故障率较高,在未来,需要更可靠和稳健的 Skyn 原型,以便在各种环境条件下进行现场测试。